Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

Chronic hepatitis C virus (HCV) infection with advanced cirrhosis or post‐liver transplantation recurrence represents a high unmet medical need with no approved therapies effective across all HCV genotypes. The open‐label ALLY‐1 study assessed the safety and efficacy of a 60‐mg once‐daily dosage of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatology
Autori principali: Poordad, Fred, Schiff, Eugene R., Vierling, John M., Landis, Charles, Fontana, Robert J., Yang, Rong, McPhee, Fiona, Hughes, Eric A., Noviello, Stephanie, Swenson, Eugene S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Viral Hepatitis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069651/
https://ncbi.nlm.nih.gov/pubmed/26754432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28446
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi